×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
DA01: Current and Future Status of Drug Development in Japan, the US, and Europe under COVID-19 Pandemic
Session Chair(s)
Hironobu Saito, PhD
Specially Appointed Professor
Tottori University, Chromosome Egineering Research Center, Japan
Junko Sato, PhD
Associate Executive Director
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Have an account?